Irritable bowel syndrome is a chronic condition that affects the gastrointestinal tract. There is no cure for IBS but many ...
AstraZeneca’s Imfinzi (durvalumab) has been granted Priority Review by the FDA for the treatment of muscle-invasive bladder cancer (MIBC), pote ...